10-QFiled 5 Nov 2026All industries
Advanced Drainage Systems, Inc.WMS
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend weakened.
The nightly ledger
Every 8-K, 10-Q and 10-K that AIR's companies filed on SEC EDGAR, and what each one changed in AIR's read. Material filings first, newest first — never ordered by price. For 8-K filing alerts, follow a company and turn on filing emails.
By event type: Acquisitions · Major contracts
Seven-day window, 2 weeks back · Material filings: 1629 · All filings: 1839
Thursday 5 Nov642 filings read · 590 material
10-QFiled 5 Nov 2026All industries
Advanced Drainage Systems, Inc.WMS
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026Biotech
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
8-KFiled 5 Nov 2026Software / SaaS
Five9, Inc.FIVN
8-K · Item 2.02 — Results of operations
Five9 reported Q3 2026 revenue of $323.3M (+13% YoY) with subscription revenue growing 16% YoY. Company announced definitive agreement to acquire Level AI for $325M cash, expected to close Q4 2026. LTM subscription retention at 109%.
Market attention has faded.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 5 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed as the filings read less positively.
10-QFiled 5 Nov 2026All industries
Opendoor Technologies Inc.OPEN
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
10-QFiled 5 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
Wednesday 4 Nov473 filings read · 428 material
8-KFiled 4 Nov 2026Biotech
8-K · Item 2.02 — Results of operations
Arcus reported positive Phase 3 progress for casdatifan across kidney cancer lines. PEAK-1 enrollment nearing completion; PEAK-20 initiating by year-end. ARC-20 data showed strong efficacy benchmarks. Cash position of $694M plus $288M equity raise supports runway into 2029.
Progress is running ahead of attention.
10-QFiled 4 Nov 2026All industries
AdvanSix Inc.ASIX
Quarterly report (10-Q), period ending 30 Sep 2026
Attention caught up with the documented progress.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
SVC reported Q3 2026 net loss of $87.9M ($0.68/share) but beat consensus on Normalized FFO ($0.34/share) and Adjusted EBITDAre ($133.5M). Board unanimously rejected TKO's $2.0B unsolicited hotel portfolio acquisition proposal as significantly undervaluing assets. Company completed 14 of 15 planned hotel sales, generating $10.3M in EBITDA losses from exited properties.
Market attention has faded.
The price trend weakened.
8-KFiled 4 Nov 2026All industries
AdvanSix Inc.ASIX
8-K · Items 2.02, 8.01 — Results of operations
Q3 2026 earnings missed expectations with net loss of $0.28/share (adjusted $0.24/share loss vs. prior year profit of $0.08/share). Sales grew 15% YoY but Adjusted EBITDA fell 41% due to reduced production output, unfavorable fixed cost absorption, and raw material inflation despite pricing actions.
Attention caught up with the documented progress.
The price trend strengthened.
8-KFiled 4 Nov 2026Industrials
8-K · Item 2.02 — Results of operations
Acushnet reported Q3 2026 net sales down 1.3% YoY but year-to-date sales up 6.8%. Net income rose 1.4% in Q3 and 14.3% YTD. Company reaffirmed full-year revenue guidance and narrowed Adjusted EBITDA outlook toward high end, citing strength in Titleist golf equipment and golf balls.
Market attention has faded.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026Industrials
Mueller Water Products, Inc.MWA
8-K · Items 2.02, 2.05 — Results of operations
Mueller Water Products announced transition of metering business to ZENNER USA, expecting ~$26M in one-time pre-tax charges (mostly Q1 FY2027). Metering contributed ~$40M in FY2026 sales. Core business showed record profitability with 3.2% sales growth and 240bps EBITDA margin expansion.
Attention caught up with the documented progress.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
Host Hotels & Resorts, Inc.HST
8-K · Item 2.02 — Results of operations
Q3 2026 comparable hotel RevPAR grew 8.8% and Total RevPAR grew 7.3%, exceeding expectations. Company raised full-year guidance for both metrics. Acquired two premium hotels (1 Hotel Brooklyn Bridge, Renaissance Dallas) and improved $2.5B credit facility terms.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026All industries
Fair Isaac CorpFICO
8-K · Item 2.02 — Results of operations
FICO reported Q4 FY2026 revenue of $657M (+27% YoY) and diluted EPS of $8.12 (+26% YoY). Scores segment grew 33%, Software ARR up 14%. However, company declined to provide FY2027 guidance due to mortgage market uncertainty and pricing transition.
No notable change in AIR's read.
10-QFiled 4 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became dearer on AIR's value read.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 sales declined 2.8% YoY to $499.5M, primarily due to July tornado impact on Wisconsin facility. FAM segment grew 10.2%, but SAS segment fell 10.9%. Adjusted EBITDA down 7% YoY to $62.3M. Company expects full-year performance ahead of prior year despite disruption.
The gap closed as the filings read less positively.
The price trend weakened.
8-KFiled 4 Nov 2026Software / SaaS
8-K · Item 2.02 — Results of operations
Q3 2026 revenue declined 3% YoY to $308.8M; GAAP operating income fell 65% YoY. Net revenue retention at 88% signals customer contraction. Guidance narrowed but maintained. Positive: million-dollar ACV cohort strong; AI product launches; debt reduction.
No notable change in AIR's read.
8-KFiled 4 Nov 2026All industries
Progyny, Inc.PGNY
8-K · Item 2.02 — Results of operations
Progyny reported record Q3 2026 results with 8.9% revenue growth to $341.3M, 15% gross profit growth, and net income of $26.3M ($0.32/share). Record 1.3M new covered lives added; near 100% client retention achieved. Company raised full-year guidance midpoint.
More of the market is starting to notice.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
Ingevity CorpNGVT
8-K · Item 2.02 — Results of operations
Q3 2026: Net income from continuing operations increased 25% YoY to $51.1M ($1.46 EPS). Adjusted EBITDA margin expanded 230 bps to 35.4%. Full-year guidance narrowed while maintaining midpoint. Performance Materials resilient; Advanced Polymer Technologies improved; Pavement Technologies pressured by input costs.
Market attention has faded.
The price trend weakened.
10-QFiled 4 Nov 2026Software / SaaS
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
No notable change in AIR's read.
8-KFiled 4 Nov 2026Industrials
Pacific Biosciences Of California, Inc.PACB
8-K · Items 2.02, 5.02 — Results of operations
CFO Jim Gibson stepped down effective November 3, 2026, transitioning to advisory role through March 31, 2027. Mark Van Oene appointed interim CFO; Bill Meyer appointed Chief Accounting Officer. Company conducting permanent CFO search.
No notable change in AIR's read.
10-QFiled 4 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 4 Nov 2026Biotech
Mineralys Therapeutics, Inc.MLYS
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
10-QFiled 4 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 revenues declined 8.1% YoY to $64.5M. Gross margin improved to 19.3% but operating loss widened due to $57.1M asset impairment and $20.8M accelerated rent charges. Adjusted EBITDA loss narrowed but company faces U.S. revenue pressure and elevated uncertainty.
No notable change in AIR's read.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 revenue of $275.4M (+27% YoY) driven by 61,500 clinical cases (+21% YoY) and ASP improvements. Company raised full-year 2026 revenue guidance to $1.04–$1.05B (28–29% growth). Net income $15.3M; Adjusted EBITDA $44.4M positive.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 4 Nov 2026Biotech
Vaxcyte, Inc.PCVX
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed — attention is catching up.
The price trend strengthened.
8-KFiled 4 Nov 2026Industrials
LivaNova PLCLIVN
8-K · Item 2.02 — Results of operations
LivaNova reported Q3 2026 revenue growth of 9.9% reported / 10.0% constant-currency, raised full-year 2026 revenue guidance by 100 bps to 9-10%, and raised adjusted diluted EPS guidance by $0.10 midpoint to $4.40-$4.50. Achieved oxygenator production capacity milestone and secured new CPT codes.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Lumen reported Q3 2026 results with 10% YoY Strategic revenue growth to $1.28B (55% of business), 4,000+ NaaS platform customers, and $700M in additional PCF deals YTD. Company reiterates 2026 guidance for $3.1–$3.3B adjusted EBITDA and $1.9–$2.1B free cash flow, remaining on track for EBITDA inflection.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026All industries
8-K · Items 2.02, 8.01 — Results of operations
SandRidge reported Q3 2026 net income of $30.6M ($0.83/share), up 92% YoY. Production increased 10% to 20.9 MBoed; revenues up 37% YoY. Company declared $0.13/share dividend and maintains zero debt with $70M cash.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 4 Nov 2026Biotech
Evolus, Inc.EOLS
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 4 Nov 2026Banks
Seacoast Banking Corp Of FloridaSBCF
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 4 Nov 2026All industries
Otter Tail CorpOTTR
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The shares became cheaper on AIR's value read.
The price trend weakened.
10-QFiled 4 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
AWR reported Q3 2026 EPS of $1.06, flat YoY but up $0.05 adjusted. YTD EPS grew 11.0% to $2.92. Water and electric segments benefited from CPUC rate increases. Contracted services awarded $31M in new projects. Dividend increased 8.2% in 2026.
Progress is running ahead of attention.
10-QFiled 4 Nov 2026All industries
Quarterly report (10-Q), period ending 26 Sep 2026
No notable change in AIR's read.
10-QFiled 4 Nov 2026Biotech
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026All industries
8-K · Items 1.01, 8.01 — Material agreement
Principal stockholder Ingram Holdco sold 11M shares at $25.90/share via secondary offering; underwriter option for 1.65M shares exercised. Company repurchased 1M shares from proceeds using existing $175M program, leaving $27.3M capacity.
The gap narrowed — attention is catching up.
The price trend weakened.
10-QFiled 4 Nov 2026Biotech
QuidelOrtho CorpQDEL
Quarterly report (10-Q), period ending 27 Sep 2026
No notable change in AIR's read.
8-KFiled 4 Nov 2026All industries
Blackstone Secured Lending FundBXSL
8-K · Item 2.02 — Results of operations
BXSL reported Q3 2026 NII of $0.68/share (10.7% annualized yield on NAV) with $0.77 dividend declared. Portfolio remains well-positioned with 95.8% first-lien debt, 2.1% non-accrual rate, and $2.6B liquidity. New investments of ~$250M and $550M+ repayments supported deleveraging.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Gulfport reported Q3 2026 net income of $96.4M and adjusted EBITDA of $226.5M. Production increased ~10% QoQ to 1,057.2 MMcfe/day with liquids up 67%. Signed new supply contracts for 50,000 MMBtu/d and expanded stock buyback authorization to $2.0B.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 4 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 4 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became dearer on AIR's value read.
10-QFiled 4 Nov 2026Industrials
Quarterly report (10-Q), period ending 26 Sep 2026
The gap narrowed — attention is catching up.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
GRAIL, Inc.GRAL
8-K · Item 2.02 — Results of operations
FDA Advisory Committee voted favorably on Galleri multi-cancer early detection test. Q3 test volume grew 24% YoY to 56K+ tests; revenue grew 14% YoY to $37.3M. Clinical trial data published showing 4-6.5x cancer detection increase and >20% reduction in Stage IV diagnoses.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026Semiconductors
8-K · Items 2.02, 8.01 — Results of operations
VIAVI reported Q1 FY2027 results significantly above guidance with 56.9% YoY revenue growth to $469.3M, GAAP operating margin of 17.4% (+1,490 bps YoY), and GAAP net income of $76.0M (+455% YoY). Board authorized $500M share repurchase program.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
GNL closed $535M accretive Modiv Industrial acquisition, reduced office exposure to 23% (targeting 18%), raised full-year AFFO guidance to $0.83–$0.85, repurchased 6.6M shares, and maintained strong liquidity of $863M with no debt maturities until Q4 2027.
No notable change in AIR's read.
8-KFiled 4 Nov 2026All industries
Cava Group, Inc.CAVA
8-K · Item 2.02 — Results of operations
CAVA reported Q3 2026 revenue growth of 22.1% YoY to $353.7M, same-restaurant sales growth of 3.1%, opened 500th location ahead of schedule, and achieved 23.4% restaurant-level profit margin despite Cyclospora headwinds.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026All industries
8-K · Items 2.02, 5.02, 8.01 — Results of operations
Hecla Mining reported Q3 2026 results with record free cash flow of $151M, income from continuing operations of $150M ($0.22/share), and $692M cash. Raised 2026 production guidance and improved cost guidance. Board expanded with new director.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Remitly reported record Q3 2026 results with 22% revenue growth to $509.8M, net income up 665% YoY to $67.6M, and Adjusted EBITDA up 97% to $120.8M. Company raised full-year 2026 outlook and increased share repurchase authorization by $300M to $500M.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 earnings declined sharply sequentially. Net income fell to $6M ($0.05/share) from $260M in Q2. EBITDA dropped 60% to $350M. PEM segment posted operating loss. Company announced facility closures in Europe and North America due to weak demand and high energy costs.
No notable change in AIR's read.
8-KFiled 4 Nov 2026All industries
Tanger Inc.SKT
8-K · Item 2.02 — Results of operations
Tanger reported Q3 2026 results with FFO of $0.64/share (vs. $0.60 prior year), Same Center NOI growth of 4.2%, and raised full-year 2026 FFO guidance to $2.49–$2.53 (from $2.45–$2.52). Occupancy stable at 97.3%; dividend increased 7%.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 4 Nov 2026Banks
Bankwell Financial Group, Inc.BWFG
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
10-QFiled 4 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 4 Nov 2026Banks
Terawulf Inc.WULF
8-K · Items 1.01, 8.01 — Material agreement
TeraWulf secured Google credit backstop for ~$19B Anthropic lease at Hawesville campus and executed definitive EPC agreement with Fluor. Google (Alphabet AA+/Aa2-rated) provides contractual credit support strengthening project financing. Fluor agreement expands construction capacity with defined milestones through Q2 2028.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026Industrials
Trimble Inc.TRMB
8-K · Item 2.02 — Results of operations
Q3 2026 revenue of $966.8M (+7% YoY) exceeded expectations; record ARR of $2.56B (+11% YoY). Non-GAAP EPS $0.86 beat guidance. FY2026 revenue guidance $3.91–3.94B maintained. Offset by $562M goodwill impairment YTD.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 4 Nov 2026All industries
NCR Atleos CorpNATL
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
Reynolds Consumer Products Inc.REYN
8-K · Item 2.02 — Results of operations
Q3 2026 revenues grew 1% YoY to $944M; adjusted EBITDA declined 3% to $163M due to 7% retail volume declines despite 9% pricing gains. Company reiterates full-year guidance and completed $110M Owl's Head Alloys acquisition.
No notable change in AIR's read.
8-KFiled 4 Nov 2026All industries
Criteo S.A.CRTO
8-K · Item 2.02 — Results of operations
Criteo reported Q3 2026 results with significant declines: revenue down 11% YoY, gross profit down 19%, Adjusted EBITDA down 39%, and Adjusted diluted EPS down 67%. FY2026 guidance reduced to -12% to -10% Contribution ex-TAC decline. Retail Media faced $20M headwind from client scope changes.
No notable change in AIR's read.
10-QFiled 4 Nov 2026Software / SaaS
Duolingo, Inc.DUOL
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 results show strong operational performance: Core RevPAR +8.1% YoY, Adjusted FFO per share +11.2% YoY to $0.39, Adjusted EBITDA +4.0% to $135M. Royal Palm reopened post-renovation; non-core dispositions progressing; debt refinanced successfully.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026All industries
Freshpet, Inc.FRPT
8-K · Item 2.02 — Results of operations
Q3 2026: Net sales +10% to $317.8M, gross margin 44.5% (vs. 39.5% prior year), Adjusted EBITDA $64.5M (+18% YoY). Company raised and narrowed 2026 guidance to 12-13% net sales growth and $215-220M Adjusted EBITDA.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 4 Nov 2026Industrials
8-K · Item 2.02 — Results of operations
Bio-Rad reported Q3 2026 revenue of $656.4M (flat YoY), with currency-neutral growth of 0.7%. Clinical Diagnostics grew 2.8% currency-neutral; Life Science declined 2.4%. Non-GAAP operating margin expanded to 12.8% from 11.8%. Company maintains 2026 guidance.
No notable change in AIR's read.
10-QFiled 4 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became dearer on AIR's value read.
The gap narrowed — attention is catching up.
The price trend strengthened.
8-KFiled 4 Nov 2026Industrials
Sunrun Inc.RUN
8-K · Item 2.02 — Results of operations
Market attention has faded.
The shares became cheaper on AIR's value read.
The price trend strengthened.
10-QFiled 4 Nov 2026All industries
Mosaic CoMOS
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
The shares became dearer on AIR's value read.
The price trend strengthened.
10-QFiled 4 Nov 2026Industrials
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026Banks
8-K · Item 2.02 — Results of operations
No notable change in AIR's read.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q2 FY2027 revenue hit record $652.7M, but net earnings fell 19% YoY to $111.5M and diluted EPS declined 14% to $3.63. Operating earnings declined across both segments despite revenue growth, driven by elevated diesel costs, higher labor/fixed costs, and pricing pressure.
No notable change in AIR's read.
10-QFiled 4 Nov 2026Biotech
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
8-KFiled 4 Nov 2026All industries
Blue Owl Technology Finance Corp.OTF
8-K · Item 2.02 — Results of operations
Q3 2026 earnings show steady NII of $0.29/share, NAV growth to $16.62 (+0.9% QoQ), and $900M new debt raised. However, non-accrual investments rose to 1.8% of portfolio cost, and new investment commitments declined 48% QoQ to $441M.
No notable change in AIR's read.
10-QFiled 4 Nov 2026Biotech
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
The gap narrowed — attention is catching up.
The price trend strengthened.
8-KFiled 4 Nov 2026Industrials
8-K · Item 2.02 — Results of operations
Q1 FY2027 net sales grew 7% YoY to $390.8M with 3% organic growth across all verticals. Medical segment surged 14% (9% organic). Company reiterates FY2027 guidance with sales expected at high end of $1,535–$1,560M range, citing Helvoet acquisition and strong Medical momentum.
The reported numbers weakened.
Market attention has faded.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 4 Nov 2026All industries
Enterprise Products Partners L.P.EPD
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
10-QFiled 4 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 4 Nov 2026Software / SaaS
Magnite, Inc.MGNI
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
Genco Shipping & Trading LtdGNK
8-K · Item 2.02 — Results of operations
Genco reported Q3 2026 net income of $38.0M ($0.87 EPS) with record $1.05/share dividend (600% YoY increase). Adjusted EBITDA surged 214% YoY to $68.1M. Q4 2026 dividend projected above $1/share. Fleet expanded with premium Capesize delivery.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
EFC reported Q3 2026 net income of $0.31/share and adjusted distributable earnings of $0.45/share. Investment portfolio grew 4.5% sequentially to $4.70B. Strong credit performance, successful $150M debt issuance, and Statebridge acquisition completed.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026Semiconductors
8-K · Items 2.02, 8.01 — Results of operations
Cirrus Logic reported Q2 FY27 revenue of $559.5M with 53.7% gross margin, driven by strong smartphone demand and custom component adoption. Company announced $500M share repurchase authorization and provided Q3 guidance of $510–570M revenue.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 4 Nov 2026Biotech
Cytokinetics IncCYTK
8-K · Item 2.02 — Results of operations
Cytokinetics reported Q3 2026 results with MYQORZO net product revenue of $44.5M, strong prescriber adoption (~1,100 providers, 2,800+ patients YTD), and positive Phase 3 ACACIA-HCM data in non-obstructive HCM. Plans supplemental NDA filing Q4 2026 and EU variation early 2027. Cash position $1.6B.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
NNN REIT reported Q3 2026 results with Core FFO and AFFO growth of 5.9% and 5.8% YoY, portfolio occupancy at 99.2% (up 170 bps YoY), $658M in acquisitions YTD at 7.3% cap rate, and maintained full-year guidance while raising disposition volume guidance.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 4 Nov 2026Banks
Renasant CorpRNST
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 4 Nov 2026All industries
Macerich CoMAC
8-K · Item 2.02 — Results of operations
Q3 2026 results show improved NOI (+4.7%), higher occupancy (94.9%), strong leasing activity (1.2M sq ft signed), and FFO growth to $0.37/share. New store openings driving traffic and sales. Two loan defaults disclosed post-quarter.
Market attention has faded.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026Software / SaaS
Magnite, Inc.MGNI
8-K · Item 2.02 — Results of operations
Magnite reported Q3 2026 results significantly exceeding guidance across all key metrics. Contribution ex-TAC grew 20% YoY, CTV surged 39%, Adjusted EBITDA grew 46% with 42% margin. Company raised full-year 2026 and 2027 guidance.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
8-K · Items 2.02, 8.01 — Results of operations
Q3 2026 net loss of $32.8M vs. prior-year loss of $70.1M. Adjusted EBITDA $97.5M slightly below prior year. Centurion mine facing geological faults constraining production; Q4 guidance reduced to 0.3–0.5M tons. Full-year volume and cost guidance lowered significantly.
Market attention has faded.
The shares became cheaper on AIR's value read.
The price trend weakened.
8-KFiled 4 Nov 2026All industries
Barrett Business Services IncBBSI
8-K · Item 2.02 — Results of operations
Q3 2026 net income declined 18% YoY to $16.8M ($0.69/share) despite 5% revenue growth. WSE growth slowed to 0.6%, gross margin compressed to 3.0% from 3.3%, and workers' compensation expense ratio increased. Soft client hiring trends noted.
Market attention has faded.
The gap closed as the filings read less positively.
The price trend weakened.
10-QFiled 4 Nov 2026Industrials
Insulet CorpPODD
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 4 Nov 2026Industrials
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 revenue declined 2% YoY to $1.0B; adjusted EPS fell to $0.42 from $0.47. North America retail slowdown and higher restructuring costs offset digital growth. FY2026 guidance reduced to flat-to-1% revenue growth.
No notable change in AIR's read.
10-QFiled 4 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 4 Nov 2026All industries
Itt Inc.ITT
8-K · Item 2.02 — Results of operations
ITT reported Q3 2026 results with 44% revenue growth to $1.4B (8% organic), adjusted EPS of $2.26 (+20% YoY), and raised full-year adjusted EPS guidance to $8.54–$8.62 (+19–20% growth). SPX FLOW acquisition contributing significantly; adjusted operating margin expanded 140 bps to 21.0%.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026All industries
Monro, Inc.MNRO
8-K · Items 1.01, 3.03 — Material agreement
Monro extended its Rights Agreement expiration from November 6, 2026 to November 1, 2027 to support ongoing strategic alternatives review and protect shareholder interests during the evaluation process.
No notable change in AIR's read.
8-KFiled 4 Nov 2026Software / SaaS
8-K · Item 2.02 — Results of operations
Paycom reported Q3 2026 revenues of $544M (+10% YoY), GAAP net income of $133M ($2.99/share), and non-GAAP net income of $150M ($3.37/share). Company raised full-year 2026 guidance to $2.213–$2.218B revenue and $1.069–$1.079B adjusted EBITDA.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 4 Nov 2026Biotech
Viridian Therapeutics, Inc.\DEVRDN
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed — attention is catching up.
The price trend strengthened.
8-KFiled 4 Nov 2026All industries
SmartStop Self Storage REIT, Inc.SMA
8-K · Item 2.02 — Results of operations
Q3 2026 earnings exceeded prior year with net income up $3.8M, FFO adjusted per share up $0.04, same-store NOI up 4.9%, and full-year guidance raised for fourth time. Strategic expansion into Canada and acquisitions underway.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 4 Nov 2026Industrials
8-K · Item 2.02 — Results of operations
Cytek reported Q3 2026 revenue of $53.2M (+2% YoY), gross margin expansion to 59% (+590 bps), installed base growth to 4,073 units, and strong U.S./high-end instrument demand. Guidance maintained at $208–211M for FY2026. Litigation update: jury found in Cytek's favor on 3 of 4 patent claims.
Progress is running ahead of attention.
8-KFiled 4 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q2 FY2027 net earnings of $136.7M exceeded prior year ($105.6M). Moving & Storage operating earnings increased $44.5M. Self-storage revenues up 6.4%, equipment rental revenues up 3.4%. Trailing twelve-month EBITDA declined $39.5M.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 4 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
Sun 22 Nov
CAPR · Capricor Therapeutics, Inc. · Regulatory date
As stated in the filing: “Deramiocel Biologics License Application (BLA) for Duchenne muscular dystrophy (DMD) under FDA review; PDUFA target action date of November 22, 2026 ●”
Announced by the company in 8-K on 10 Nov 2026
DYN · Dyne Therapeutics, Inc. · Regulatory date
As stated in the filing: “Capricor Therapeutics’ BLA for its cell therapy deramiocel is currently under FDA review with a PDUFA date of November 22, 2026.”
Announced by the company in 10-Q on 5 Nov 2026
SVRA · Savara Inc · Regulatory date
As stated in the filing: “The FDA determined that the Company’s responses to recent information requests by the Agency during its review constituted a major amendment to the BLA, resulting in a three-month extension of the Prescription Drug User Fee Act ("PDUFA") target action date to November 22, 2026.”
Announced by the company in 10-Q on 9 Nov 2026
Fri 27 Nov
BBIO · BridgeBio Pharma, Inc. · Regulatory date
As stated in the filing: “The first participant was dosed in ASCEND-ATTR, the Phase 3b/4 study to prospectively test disease reversal with Attruby - BBP-418 for LGMD2I/R9 has a November 27, 2026 PDUFA date, with Priority Review.”
Announced by the company in 8-K on 29 Oct 2026
Mon 30 Nov
COGT · Cogent Biosciences, Inc. · Regulatory date
As stated in the filing: “Potential FDA approval of bezuclastinib in GIST – PDUFA date of November 30, 2026 •”
Announced by the company in 8-K on 5 Nov 2026
JBIO · Jade Biosciences, Inc. · Regulatory date
As stated in the filing: “The FDA has also accepted a Biologics License Application for accelerated approval of povetacicept in IgAN, with a Prescription Drug User Fee Act target action date of November 30, 2026.”
Announced by the company in 10-Q on 13 Nov 2026
Wed 2 Dec
ARE · Alexandria Real Estate Equities, Inc. · Investor day
As stated in the filing: “We expect to introduce 2027 guidance and related assumptions at our Investor Day on December 2, 2026, consistent with our historical practice.”
Announced by the company in 8-K on 27 Apr 2026
Thu 3 Dec
EXEL · Exelixis, Inc. · Regulatory date
As stated in the filing: “In February 2026, we announced that the FDA had accepted our NDA and assigned a standard review, with a Prescription Drug User Fee Act (PDUFA) target action date of December 3, 2026.”
Announced by the company in 10-Q on 29 Oct 2026
Tue 8 Dec
GPC · Genuine Parts Co · Investor day
As stated in the filing: “In addition, the Company announced that both Global Automotive and Global Industrial will host separate investor days on December 8, 2026 and December 9, 2026, respectively.”
Announced by the company in 8-K on 9 Sep 2026
LGND · Ligand Pharmaceuticals Inc · Investor day
As stated in the filing: “Ligand will provide an updated 5-year outlook during the Company’s Investor Day on December 8, 2026.”
Announced by the company in 8-K on 14 Jul 2026
Wed 9 Dec
GPC · Genuine Parts Co · Investor day
As stated in the filing: “Investor Days GPC and Motion will host separate investor days in New York City, with GPC’s Investor Day scheduled for December 8, 2026, and Motion’s Investor Day scheduled for December 9, 2026.”
Announced by the company in 8-K on 9 Sep 2026
Sat 12 Dec
ANAB · Anaptysbio, Inc · Regulatory date
As stated in the filing: “FDA target action date (PDUFA) of December 12, 2026, for Quimilza in generalized pustular psoriasis (GPP) GSK and Tesaro Litigation Update •”
Announced by the company in 8-K on 12 Nov 2026
Thu 17 Dec
CORT · Corcept Therapeutics Inc · Regulatory date
As stated in the filing: “Relacorilant for patients with Cushing’s syndrome – Resubmitted New Drug Application Prescription Drug User Fee Act (PDUFA) date of December 17, 2026 “The ADA and EASD consensus statement is an important advance for the many patients whose difficult-to-control hyperglycemia is a manifestation of undiagnosed Cushing’s syndrome,” said Bill Guyer, PharmD, Corcept’s Chief Development Officer.”
Announced by the company in 8-K on 3 Nov 2026
Mon 23 Nov
MATW · Matthews International Corp · All industries
Annual results due — last year filed 21 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 30%, net income turned to a loss
AIR's current read: News flow Balanced, Gap Low · 0
Tue 24 Nov
BLBD · Blue Bird Corp · Industrials
Annual results due — last year filed 24 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 30%, net income up 408%
AIR's current read: News flow Balanced, Gap Very high · 82
PFLT · PennantPark Floating Rate Capital Ltd. · All industries
Annual results due — last year filed 24 Nov 2025
AIR's current read: News flow Balanced, Gap Very high · 71
Wed 25 Nov
AMTM · Amentum Holdings, Inc. · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2025, against a year earlier): revenue up 66%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 4
ARMK · Aramark · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2025, against a year earlier): revenue up 6%, net income up 23%
AIR's current read: News flow Balanced, Gap Medium · 10
CASH · Pathward Financial, Inc. · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 3%, net income down 31%
AIR's current read: News flow Balanced, Gap Low · 0
CLSK · Cleanspark, Inc. · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2024, against a year earlier): revenue up 129%, net loss widened
AIR's current read: News flow Balanced, Gap Very high · 54
GAP · Gap Inc · All industries
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q3 2024, against a year earlier): revenue down 7%, net income down 23%
AIR's current read: News flow Balanced, Gap Low · 3
ROAD · Construction Partners, Inc. · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 28%, net income up 35%
AIR's current read: News flow Balanced, Gap Low · 7
SJM · J M SMUCKER Co · All industries
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 7%, net loss widened
AIR's current read: News flow Balanced, Gap Low · 7
SMG · Scotts Miracle-Gro Co · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 1%, net income down 25%
AIR's current read: News flow Balanced, Gap Medium · 12
SMTC · Semtech Corp · Semiconductors
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q1 2027, against a year earlier): revenue up 16%, net income up 37%
AIR's current read: News flow Balanced, Gap Low · 0
TFSL · TFS Financial CORP · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q1 2019, against a year earlier): net income up 4%
AIR's current read: News flow Balanced, Gap Medium · 23
Fri 27 Nov
ATKR · Atkore Inc. · Industrials
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 8%, net income down 98%
AIR's current read: News flow Balanced, Gap Low · 0
BJ · BJ's Wholesale Club Holdings, Inc. · All industries
Quarterly results due — last year filed 26 Nov 2025
Last quarter (Q2 2027, against a year earlier): revenue up 16%, net income up 15%
AIR's current read: News flow Balanced, Gap Medium · 18
CENT · Central Garden & Pet Co · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 8%, net income down 5%
AIR's current read: News flow Balanced, Gap Low · 1
CFFN · Capitol Federal Financial, Inc. · Banks
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2020, against a year earlier): net income down 15%
AIR's current read: News flow Balanced, Gap Medium · 10
JJSF · J&J Snack Foods Corp · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 6%, net income down 20%
AIR's current read: News flow Balanced, Gap Low · 0
PD · PagerDuty, Inc. · Software / SaaS
Quarterly results due — last year filed 26 Nov 2025
Last quarter (Q1 2027, against a year earlier): revenue up 1%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 0
SPH · Suburban Propane Partners Lp · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue unchanged, net loss widened
AIR's current read: News flow Balanced, Gap Medium · 21
UTI · Universal Technical Institute Inc · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 7%, net income down 79%
AIR's current read: News flow Balanced, Gap Very high · 57
Mon 30 Nov
SNEX · StoneX Group Inc. · All industries
Annual results due — last year filed 28 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 15%, net income up 102%
AIR's current read: News flow Balanced, Gap Very high · 52
Tue 1 Dec
ESE · Esco Technologies Inc · Industrials
Annual results due — last year filed 1 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 14%, net income up 26%
AIR's current read: News flow Balanced, Gap Very high · 97
Wed 2 Dec
ASAN · Asana, Inc. · Software / SaaS
Quarterly results due — last year filed 2 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 10%, net loss narrowed
AIR's current read: News flow Balanced, Gap Low · 0
UNFI · United Natural Foods Inc · All industries
Quarterly results due — last year filed 2 Dec 2025
AIR's current read: News flow Balanced, Gap Low · 0
VSTS · Vestis Corp · All industries
Annual results due — last year filed 2 Dec 2025
Last quarter (Q3 2025, against a year earlier): revenue down 4%, net income turned to a loss
AIR's current read: News flow Balanced, Gap Low · 1
Thu 3 Dec
BOX · Box Inc · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 9%, net income up 43%
AIR's current read: News flow Balanced, Gap Low · 1
CRWD · CrowdStrike Holdings, Inc. · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 26%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 5
HQY · Healthequity, Inc. · All industries
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 8%, net income up 10%
AIR's current read: News flow Balanced, Gap Low · 0
KSS · KOHLS Corp · All industries
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q3 2024, against a year earlier): revenue down 5%, net income down 39%
AIR's current read: News flow Balanced, Gap Medium · 11
MEI · Methode Electronics Inc · Industrials
Quarterly results due — last year filed 3 Dec 2025
AIR's current read: News flow Balanced, Gap Low · 0
NCNO · nCino, Inc. · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 11%, net income up 145%
AIR's current read: News flow Balanced, Gap Low · 5
THO · Thor Industries Inc · Industrials
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q4 2026, against a year earlier): revenue down 8%, net income down 68%
AIR's current read: News flow Balanced, Gap Low · 4
Fri 4 Dec
AGX · Argan Inc · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 62%, net income up 51%
AIR's current read: News flow Balanced, Gap Low · 9
AMBA · Ambarella Inc · Semiconductors
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 13%, net loss narrowed
AIR's current read: News flow Balanced, Gap Low · 7
BF-B · Brown Forman Corp · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue down 1%, net income up 4%
AIR's current read: News flow Balanced, Gap Low · 0
CXM · Sprinklr, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 1%, net income down 44%
AIR's current read: News flow Balanced, Gap Low · 9
DCI · DONALDSON Co INC · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q4 2026, against a year earlier): revenue up 8%, net income up 13%
AIR's current read: News flow Balanced, Gap Low · 9
FIVE · Five Below, Inc · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2024, against a year earlier): revenue up 14%, net income down 10%
AIR's current read: News flow Balanced, Gap High · 27
GWRE · Guidewire Software, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 27%, net income down 64%
AIR's current read: News flow Balanced, Gap High · 44
NTNX · Nutanix, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 10%, net income up 14%
AIR's current read: News flow Balanced, Gap Medium · 22
REX · REX AMERICAN RESOURCES Corp · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 6%, net income up 336%
AIR's current read: News flow Balanced, Gap Low · 0
SAIC · Science Applications International Corp · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
AIR's current read: News flow Balanced, Gap High · 39
SWBI · Smith & Wesson Brands, Inc. · Industrials
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 32%, net income turned positive
AIR's current read: News flow Balanced, Gap Very high · 87
TITN · Titan Machinery Inc. · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue down 9%, net loss widened
AIR's current read: News flow Balanced, Gap Low · 0
Expected dates come from each company's filing history. They are not forecasts, and companies move them.
Sign in to follow companies
Follow a company and its filings show up here.
Sign inResearch, not tips. Filings come from SEC EDGAR; AIR's read is recomputed every trading day. A price move is shown as a fact beside a filing, never as the reason it is listed.